companydata.dkcompanydata.dk

Mohammad Sohail Asghar

PersonUnit number: 4000423976
Address protected
1
Ownership
4
Board positions
4
Director positions
2
Other roles
26
People in network

People in network(26)

People who held roles at the same companies, or who co-own the same companies

Jens-Nikolaj Schøier
Frederiksstaden Pharma ApS, XGX Pharma ApS, XGX Pharma ApS, XGX Pharma ApS, Vautia Therapeutics ApS
Lars Karlsmose
XGX Pharma ApS, HB MEDICAL SCANDINAVIA A/S, HB MEDICAL SCANDINAVIA A/S
Rolf Eckersberg
Frederiksstaden Pharma ApS, Frederiksstaden Pharma ApS

Ownership(1)

MSA ApS
CVR: 32261221
EJERREGISTER
100%
Ownership
Active

Board positions(1)

SAIM Medical ApS
CVR: 41837071
BESTYRELSESMEDLEM
Active
Since 16. nov. 2020

Director positions(1)

Vautia Therapeutics ApS
CVR: 45465578
DIREKTØR
Active
Since 11. mar. 2025

Other roles(1)

MSA ApS
CVR: 32261221
STIFTERE
Active
Since 3. jun. 2009

Indirect ownership(3)

Companies owned indirectly through ownership chains.

50-66,65%
Effective ownership
Depth: 1
Ownership path:
MSA ApS(100%)
→Vautia Therapeutics ApS(50-66,65%)
SAIM Medical ApS
CVR: 41837071
33,33-49,99%
Effective ownership
Depth: 1
Ownership path:
MSA ApS(100%)
→SAIM Medical ApS(33,33-49,99%)
33,33-49,99%
Effective ownership
Depth: 1
Ownership path:
MSA ApS(100%)
→Simplified Medtech Solutions ApS(33,33-49,99%)

Former board positions(3)

Frederiksstaden Pharma ApS
CVR: 25630483
BESTYRELSESMEDLEM
Ended
Since 2. dec. 2019
Until 5. maj 2022
XGX Pharma ApS
CVR: 32289290
FORMAND
Ended
Since 10. maj 2022
Until 21. jul. 2025
HB MEDICAL SCANDINAVIA A/S
CVR: 37638862
BESTYRELSESMEDLEM
Dissolved
Ended
Since 2. dec. 2019
Until 2. dec. 2019

Former director positions(3)

MSA ApS
CVR: 32261221
ADM. DIR.
Ended
Since 3. jun. 2009
Until 16. mar. 2011
XGX Pharma ApS
CVR: 32289290
DIREKTØR
Ended
Since 14. jul. 2009
Until 1. dec. 2017
SAIM Medical ApS
CVR: 41837071
DIREKTØR
Ended
Since 10. nov. 2020
Until 10. nov. 2020

Former roles(1)

PharmaXam
CVR: 26504384
INTERESSENTER
Dissolved
Ended
Since 1. feb. 2002
Until 31. dec. 2017